[Selective biopsy of the sentinel ganglion in patients with breast cancer. Initial results].
BACKGROUND
Sentinel-node biopsy is meant to excise the first-echelon node from a primary tumor, which is the one that most probably harbors early metastases.


METHODS
We report our results in 35 patients with breast cancer, using a radiotracer by peri-tumoral injection, pre-surgical scintigraphy and intraoperative mapping with a gamma probe.


RESULTS
The technical success rate was 97%, negative predictive value 95.2%, accuracy 97%, and added value to staging 40%.


CONCLUSIONS
Compared with the conventional lymph-node staging procedure for breast cancer, sentinel-node biopsy with pre-surgical scintigraphy seems a good practical choice.
Fraile
M
M
Servicio de Medicina Nuclear, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona. mfraile@ns.hugtip.scs.es
Rull
M
M
Julian
J F
JF
Castellà
E
E
Barnadas
A
A
Alastrué
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery; D002277:Carcinoma / Q000473:pathology* / Q000601:surgery; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis / Q000473:pathology; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011300:Preoperative Care; D019275:Radiopharmaceuticals; D012189:Retrospective Studies
D019275:Radiopharmaceuticals
Biopsia selectiva del ganglio centinela en pacientes con cáncer de mama. Primeros resultados.